PDCD1 and cancer: PD-1 is expressed by activated lymphocytes and interactions of PD-1 with its ligand PD-L1, which is also expressed by neoplastic cells [5, 6] lead to a reduction of T-lymphocyte activity in normal tissue, during inflammation, in cancer and decreases autoimmunity [5, 7, 8].